Posterior ocular involvement in Behçet's disease and thrombophilic mutations

Clinical Hemorheology and Microcirculation

Volumn 51, Issue 3, 2012, Pages 225-228

  Vayá, Amparo ^a   Miguel De La Fuente, José ^a   Suescun, Marta ^a   Espaa, Enrique ^a   Ricart, José M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Beh et's disease; C677T MTHFR mutation; factor V Leiden; posterior ocular involvement; prothrombin G20210A mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BEHCET DISEASE; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SPAIN; THROMBOPHILIA;

ADULT; BEHCET SYNDROME; FACTOR V; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PROTHROMBIN; THROMBOPHILIA;

EID: 84863331060     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1548     Document Type: Article

References (21)

1. A. Altinbas, K. Aytemur, L. Tokgozoglu, et al., Hyperhomocysteinaemia and activated protein C resistance in Behçet's disease, J Intern Med 248 (2000), 267-268.
2. Anonymous, Ethical guidelines for publication in Clinical Hemorheology and Microcirculation, Clin Hemorheol Microcirc 44 (2010), 1-2.
3. F. Batioglu, L.S. Atmaca, H.G. Karabulut, et al., Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease, Acta Ophtalmol Scand 81 (2003), 283-285.
4. E. Bloch-Michel and Rb. Nussemblatt, International uveitis study group recommendations for the evaluation of intraocular inflammatory disease, Am J Ophthalmol 103 (1987), 234-235.
5. P. Caramaschi, G. Poli, A. Bonora, et al., A study on thrombophilic factors in Italian Behcet's patients, Joint Bone Spine 77 (2010), 330-334.
6. Y. Chen, M.R. Stanford, G.R. Wallace, et al., Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease, Br J Ophtalmol 8 (2003), 1048-1049.
7. M. Citirik, I.C. Haznedaroglu, K. Teberik, et al., Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement, Br J Ophtalmol 93 (2009), 1382-1386.
8. E. Dagan, Y. Baruch, M. Fiorilli, et al., Vascular Behçet and mutations in thrombogenic genes: Methylene tetrahydrofolate reductase, factor V, and prothrombin, Genet Test Mol Biomarkers 16 (2012), 30-35.
9. F. Davatchi, F. Shahram, C. Chams-Davatchi, et al., Behçet's disease: From east to west, Clin Rheumatol 29 (2010), 823-833.
10. M. Franchini and D. Veneri, Inherited thrombophilia: An update, Clin Lab 51 (2005), 357-365.
11. M. Guillen, D. Corella, O. Portoles, et al., Prevalence of the methylenetetrahydrofolate reductase 677C T mutation in the Mediterranean Spanish population, Association with cardiovascular risk factors, Eur J Epidemiol 170 (2001), 255-256.
12. International Study Group for Behçet's disease. Criteria for the diagnosis of Behçet's disease, Lancet 335 (1990), 1078-1080.
13. A. Kosar, I.C. Haznedaroglu, Y. Buyukasik, et al., Activated protein C resistance in Behçet's disease, Rheumatol Int 17 (1998), 249-250.
14. M. Leiba, U. Seligsohn, Y. Sidi, et al., Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease, Ann Rheum Dis 63 (2004), 1445-1449.
15. Y. Özkul, Evereklioglu, M. Borlu, et al., 5,10- Methylenetetrahydrofolate reducatase C677T gene polymorphism in Behçet's patients with or without ocular involvement, Br J Ophthalmol 89 (2005), 1634-1637.
16. E. Pato, S. Muñoz-Fernández, F. Francisco, et al., Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis, Semin Arthritis Rheumatol 40 (2011), 314-323.
17. K. Probst, R. Fijnheer, A. Rothova, Endothelial cell activation and hypercoagulability in ocular Behçet's disease, Am J Ophthalmol 137 (2004), 850-857.
18. J.M. Ricart, A. Vayá, J. Todoĺi, et al., Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events, Thromb Haemost 95 (2006), 618-624.
19. F. Sáenz-Francés, M. Eĺias-de-Tejada, J.M. Mart́inez-de-la-Casa, et al., Ocular inflammatory signs observed in a cohort of Spanish patients with Behçet disease and ocular inflammation, Eur J Ophthalmol 18 (2008), 563-566.
20. A. Vayá, Y. Mira, J. Mateo, et al., Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk, Thromb Haemost 89 (2003), 452-457.
21. D.H. Verity, R.W. Vaughan, W. Madanat, et al., Factor V Leiden mutation is associated with ocular involvement in Behçet disease, Am J Ophthalmol 128 (1999), 352-356.